Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-25-002558

Chief Scientific Officer gave up 4,324 shares (to pay taxes)

  • Chief Scientific Officer acquired 9,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Or Yat Sun Chief Scientific Officer 2025-02-12 Grant or award +9,750 378,859 D: show line 1 in the form
Or Yat Sun Chief Scientific Officer 2025-02-12 Shares withheld for taxes −4,324 $5.59 $24,171 374,535 D: show line 2 in the form
Loading xslF345X05/form4.xml…